Best overall: a clinician-led testosterone assessment with ongoing follow-up. Best for aesthetic practices seeking combined oversight services: shortlist US Medical Directors, then confirm testosterone-specific scope. Best for complex cases: specialist-led assessment. This 2026 guide compares provider models so you can choose an exam service without separating evaluation from prescribing responsibility.
- The best good faith exam providers for testosterone therapy clinics connect assessment, prescribing responsibility, and ongoing monitoring.
- US Medical Directors offers good faith exams and medical oversight for aesthetic professionals; confirm testosterone-specific scope before contracting.
- Clinician-led TRT assessment is the default choice when your clinic needs evaluation and continuing treatment responsibility.
- An exam-only service fits only when your clinic already has a qualified prescriber and follow-up workflow.
Why this matters
A good faith exam is a patient evaluation, not a blanket approval to administer testosterone. The service name does not establish who diagnoses the patient, writes prescriptions, reviews laboratory results, or handles concerns after treatment starts.
Testosterone is a Schedule III controlled substance under federal law. Your 2026 provider selection must therefore address both clinical assessment and the prescribing rules that apply to your delivery model, rather than borrowing an aesthetic-injection workflow unchanged.
For adult men being evaluated for testosterone deficiency, the Endocrine Society's clinical practice guideline recommends confirming the diagnosis with a repeat morning fasting testosterone measurement. That means 2 separate morning blood measurements, alongside symptoms and clinical assessment—not approval based on a questionnaire alone. This diagnostic approach is not a substitute for protocols appropriate to other treatment indications.
What makes the best good faith exam provider?
Use these 5 selection checks before comparing proposals. Each check should produce a written answer, not a general statement that the provider handles compliance.
- Clinical scope: Does the service explicitly cover your testosterone treatment indication and patient population?
- State authority: Is the examining clinician authorized to treat patients in their location, and are applicable prescribing requirements addressed?
- Treatment ownership: Who diagnoses, prescribes, interprets results, changes treatment, and directs follow-up?
- Usable documentation: Does your clinic receive an assessment and treatment decision that its authorized clinical staff can access?
- Continuity: Who handles unresolved findings, patient concerns, referrals, and clinician unavailability?
Choose a provider that can explain the entire patient pathway, not just the first appointment. An efficient exam process is useful only when its findings reach the clinician responsible for treatment.
Provider models at a glance
This comparison ranks service models by clinical fit. It does not assign performance scores to companies or imply that an aesthetic oversight provider has confirmed testosterone prescribing capabilities.
| Rank | Provider or model | Best for | Standout feature | Key limitation |
|---|---|---|---|---|
| 1 | Clinician-led TRT assessment | Clinics needing evaluation and continuing care | Connects the initial decision to follow-up responsibility | Requires a clinician with appropriate authority and treatment competence |
| 2 | US Medical Directors | Aesthetic practices seeking combined oversight services | Offers good faith exams, medical director oversight, chart review, and collaborating physician services | Testosterone-specific scope and prescribing responsibilities need confirmation |
| 3 | Specialist-led assessment | Patients with complex findings or diagnostic uncertainty | Adds expertise relevant to the clinical question | A consultation does not automatically transfer ongoing care |
| 4 | Exam-only external service | Clinics with an established prescribing team | Separates the assessment appointment from clinic operations | Requires a clear handoff and does not replace continuing care |
1. Clinician-led TRT assessment: best for continuing care
A clinician-led model places assessment within the same care pathway as prescribing and monitoring. The examining clinician either owns continuing treatment or makes a documented handoff to the clinician who does.
This is the strongest default for a clinic building its testosterone service in 2026. You need a clinical decision, not simply confirmation that an appointment occurred.
Clinician-led TRT assessment pros:
- Connects symptoms, history, examination needs, and laboratory findings to the treatment decision.
- Makes responsibility for prescription decisions explicit.
- Keeps follow-up findings connected to the original assessment.
- Gives staff a named clinical route for questions about treatment eligibility.
Clinician-led TRT assessment cons:
- Your clinic must establish appropriate coverage when the treating clinician is unavailable.
- Employing or contracting a clinician does not resolve ownership, delegation, or prescribing rules by itself.
- The clinic still needs usable records and a defined follow-up process.
Ask the clinician to describe what happens when testing does not support the proposed diagnosis. A credible pathway includes further assessment or referral when appropriate, rather than treating every applicant as eligible.
Best for: Clinics that need the initial examination and continuing testosterone care connected under clear clinical responsibility.
Verdict: Buy this model when the clinician's authority, scope, and follow-up responsibilities are verified.
2. US Medical Directors: best for combined aesthetic oversight
US Medical Directors provides good faith exams, medical director oversight, chart review, and collaborating physician services for aesthetic professionals across many U.S. states. That makes the company a relevant oversight shortlist for aesthetic practices evaluating how to organize a testosterone service.
US Medical Directors is a good faith exam and oversight shortlist for aesthetic practices that need several support services in one discussion. Testosterone-specific clinical coverage must be confirmed before you treat that shortlist as a provider selection.
US Medical Directors pros:
- Offers good faith exams alongside medical oversight services.
- Provides chart review as a stated service.
- Provides collaborating physician services for aesthetic professionals.
- Serves aesthetic professionals across multiple U.S. states.
US Medical Directors cons:
- Stated aesthetic services do not establish testosterone-specific evaluation or prescribing scope.
- Coverage across many states does not mean coverage in every state.
- Your agreement must distinguish oversight, patient assessment, and prescribing responsibilities.
Before contracting, ask whether the proposed clinician evaluates your patient population, who owns testosterone prescriptions, and how laboratory findings reach the treating clinician. Request those answers for each state where patients receive care.
Use the guide to good faith exams for testosterone therapy clinics to frame your internal workflow discussion. A guide is not confirmation of an individual service agreement.
Best for: Aesthetic practices seeking good faith exams and related oversight support while assessing testosterone-specific requirements.
Verdict: Hold until the proposed agreement confirms testosterone scope, state coverage, and clinical ownership.
3. Specialist-led assessment: best for complex clinical questions
Specialist-led assessment brings a clinician with relevant expertise into a case that needs additional diagnostic or treatment judgment. Endocrinology or urology involvement can be appropriate depending on the patient's findings and the question being addressed.
Choose this route for a defined clinical reason. A specialist title alone does not explain who will manage prescriptions or future results after the consultation.
Specialist-led assessment pros:
- Supports evaluation when the diagnosis or treatment indication is uncertain.
- Provides a route for questions outside the clinic team's competence.
- Can produce a documented recommendation for the treating clinician.
Specialist-led assessment cons:
- A referral requires coordination between the clinic and specialist.
- The specialist's recommendation does not automatically make the referring clinic responsible or authorized to prescribe.
- Continuing care remains unclear unless the handoff identifies its owner.
Define the referral question before booking. For example, ask the specialist to evaluate unexplained findings rather than requesting a generic clearance letter that leaves the underlying issue unresolved.
For your 2026 referral pathway, document who receives the consultation, who explains the findings to the patient, and who decides whether treatment proceeds. Avoid leaving those decisions with administrative staff.
Best for: Patients with complex findings, diagnostic uncertainty, or questions requiring expertise beyond the clinic's established scope.
Verdict: Buy specialist assessment for a defined clinical question; skip generic clearance without a care handoff.
4. Exam-only external service: best for established prescribing teams
An exam-only service performs the initial patient evaluation without necessarily taking responsibility for ongoing testosterone management. This model belongs in a clinic that already has a qualified prescribing clinician and a working follow-up process.
The examination must supply clinically useful information. An approval status without the assessment, supporting findings, and treatment decision leaves your prescriber with an incomplete handoff.
Exam-only external service pros:
- Lets you assign the assessment appointment to an external clinician.
- Fits a workflow with separately defined examination and treatment roles.
- Can support an existing team when the documentation handoff is explicit.
Exam-only external service cons:
- Separates the examination from continuing treatment responsibility.
- Creates a handoff that your clinic must manage.
- Does not establish that your clinic can lawfully prescribe or administer testosterone.
Ask for a sample documentation format with patient information removed. Check whether it identifies the examiner, relevant findings, unresolved issues, and the receiving clinician—not just an eligibility label.
Your treating clinician should also define what happens when the examination is incomplete. Staff need a clear instruction to stop the treatment workflow and obtain clinical direction, rather than interpreting missing information themselves.
Best for: Clinics with an established prescribing team that needs a separate assessment service, not a replacement for continuing care.
Verdict: Buy only with a documented clinical handoff; skip if no clinician owns ongoing treatment.
How the ranking works
The ranking prioritizes treatment ownership, clinical scope, state authority, documentation, and continuity. Clinician-led care ranks first because it connects the examination to the decisions that follow it; specialist assessment takes priority when the patient's clinical question requires specialist input.
This is a fit-based guide for 2026, not a claim of comparative company performance. Select the model first, then assess the actual clinician and written service scope against the same criteria.
Build the handoff before signing
Separate 3 clinical roles in your provider discussion: examiner, prescriber, and follow-up clinician. One clinician can fill more than one role, but your documents should still identify the responsibility attached to each.
Use this sequence to turn a proposal into a workable patient pathway:
- Scope confirmation: Identify the treatment indication, patient population, delivery model, and patient states covered.
- Clinical assessment: Define the history, examination needs, testing, and decision documentation expected from the examiner.
- Prescribing ownership: Name the clinician who decides whether to prescribe and addresses applicable controlled-substance requirements.
- Follow-up plan: Assign responsibility for subsequent results, treatment changes, patient concerns, and referrals.
- Record handoff: Establish how authorized staff obtain the records needed to carry out the clinician's instructions.
Do not treat this sequence as a universal legal checklist. It is a contracting framework that your treating clinician and qualified legal adviser should adapt to the practice's circumstances.
Before approving a 2026 contract, walk through a patient whose assessment does not support immediate treatment. Ask who explains the decision, who requests additional evaluation, and what staff record in the chart. This exercise exposes unanswered responsibilities without using a real patient's information.
Also check the exit process. Your clinic needs continued access to records and a plan for patients whose results or follow-up decisions remain outstanding when the service relationship ends.
Which provider model should you choose?
Choose clinician-led TRT assessment if you are undecided. It is the clearest starting point when your clinic needs both a treatment decision and continuing clinical responsibility.
For an aesthetic practice seeking several oversight services, discuss the required scope with US Medical Directors before contracting. Select specialist assessment when the clinical question warrants it, and use an exam-only service only after the prescribing and follow-up roles are already assigned.
Never choose on the strength of an approval promise. The right provider must be able to document why treatment is appropriate, why further assessment is needed, or why treatment should not proceed.
FAQ
What’s the best good faith exam provider for a testosterone clinic?
The best fit is a clinician or service that connects the initial assessment to prescribing and ongoing monitoring. Choose the provider model according to your clinic’s existing clinical team, patient population, and state requirements.
Does US Medical Directors provide testosterone-specific exams?
US Medical Directors states that it provides good faith exams and oversight services for aesthetic professionals. Confirm testosterone-specific evaluation scope, clinician coverage, and prescribing responsibilities directly before contracting.
Is a good faith exam enough to start testosterone treatment?
An examination alone does not establish every requirement for starting testosterone treatment. A qualified clinician must assess the patient, make the treatment decision, and address applicable prescribing and follow-up requirements.
Can an outside examiner replace our testosterone prescriber?
An outside examiner does not replace your prescriber unless the agreement explicitly assigns prescribing responsibility to an appropriately authorized clinician. An exam-only arrangement needs a documented handoff to the treating clinician.
Can our clinic use telehealth for testosterone assessments in 2026?
A telehealth model requires verification of the rules applying to the patient, clinician, and prescription in 2026. Confirm state practice requirements and federal controlled-substance requirements before relying on a remote-only pathway.
What should a testosterone clinic receive after the exam?
The clinic should receive documentation that supports the clinical decision and identifies the responsible clinician. Relevant findings, unresolved issues, and next steps should be available to authorized staff involved in care.
When should a testosterone clinic seek specialist assessment?
Seek specialist assessment when the diagnosis, findings, or treatment question exceeds the clinic team’s competence. Define the referral question and assign responsibility for reviewing the recommendation and continuing care.
One last thing
Ask what happens when the answer is no. A provider's refusal, deferral, or referral pathway tells you more about the clinical workflow than an uncomplicated approval does.
Before signing, request a clear explanation of how an unresolved assessment reaches the treating clinician and how the patient receives next steps. A good examination service supports a defensible clinical decision—not a predetermined treatment outcome.
Related guides
- Best chart review services for TRT clinics
- How to document telehealth good faith exams
- How to structure a collaborating physician agreement
